CARDIOVASCULAR: TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?

Audio Journal of Cardiovascular Medicine, November 6th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent? GREGG STONE, Columbia University, New York REFERENCE: Abstract 2357 New light has been thrown on the use of thienopyridine therapy after percutaneous intervention using drug-eluting stents. Gregg Stone presented data from the TAXUS DES trials which looked at patients surviving more than a year after receiving either paclitaxel-eluting or bare metal stents. After his talk at the American Heart Association he discussed his findings with Sarah Maxwell.